Burgess Thomas B, Condliffe Alison M, Elks Philip M
The Bateson Centre, University of Sheffield, Western Bank, Sheffield S10 2TN, UK.
Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Beech Hill, Sheffield S10 2RX, UK.
J Fungi (Basel). 2022 Jul 29;8(8):805. doi: 10.3390/jof8080805.
Immunocompromised individuals are at high risk of developing severe fungal infections with high mortality rates, while fungal pathogens pose little risk to most healthy people. Poor therapeutic outcomes and growing antifungal resistance pose further challenges for treatments. Identifying specific immunomodulatory mechanisms exploited by fungal pathogens is critical for our understanding of fungal diseases and development of new therapies. A gap currently exists between the large body of literature concerning the innate immune response to fungal infections and the potential manipulation of host immune responses to aid clearance of infection. This review considers the innate immune mechanisms the host deploys to prevent fungal infection and how these mechanisms fail in immunocompromised hosts. Three clinically relevant fungal pathogens (, spp. and spp.) will be explored. This review will also examine potential mechanisms of targeting the host therapeutically to improve outcomes of fungal infection.
免疫功能低下的个体极易发生严重的真菌感染,死亡率很高,而真菌病原体对大多数健康人几乎没有风险。治疗效果不佳和不断增加的抗真菌耐药性给治疗带来了进一步的挑战。确定真菌病原体利用的特定免疫调节机制对于我们理解真菌疾病和开发新疗法至关重要。目前,在大量关于真菌感染的固有免疫反应的文献与潜在操纵宿主免疫反应以帮助清除感染之间存在差距。本综述考虑了宿主用于预防真菌感染的固有免疫机制,以及这些机制在免疫功能低下的宿主中是如何失效的。将探讨三种临床相关的真菌病原体(、属和属)。本综述还将研究以宿主为靶点进行治疗以改善真菌感染结果的潜在机制。